Anadolu Medical Center
Anadolu Medical Center
Turquie, Istanbul
Bulent Karagoz
33 années d'expérience
La clinique est certifiée :
Le coût du traitement de l"ostéosarcome en Turquie varie en fonction du plan de traitement. Les diagnostics initiaux, y compris les consultations, les scanners et les IRM, vont de 190 € à 1 900 €. Les séances de chimiothérapie, impliquant des médicaments comme MEPACT et ADRIAMYCIN, vont de 330 € pour une chimiothérapie ambulatoire à 13 200 € pour des séances plus étendues. Les interventions chirurgicales, y compris la reconstruction modulaire avec une prothèse tumorale, peuvent coûter plus de 34 900 €. Des traitements supplémentaires comme la radiothérapie sur des appareils tels que l"ELECTRA 2020 full HD+ sont tarifés autour de 4 700 €. Le plan de traitement est adapté à chaque patient après une évaluation approfondie par des professionnels de santé.
Plus de 900 interventions sur l'ostéosarcome – Le Dr Bülent Karagöz se spécialise en biologie tumorale et en immunothérapie au centre médical Anadolu.
Le Dr Mustafa Solak a réalisé plus de 900 traitements pour divers cancers en tant qu'oncologue clinicien à l'hôpital Hisar Intercontinental.
Le Dr Eda Tanrikulu est spécialisée en oncologie médicale et en chimiothérapie au centre médical Anadolu – l'un des principaux établissements de traitement du cancer en Turquie.
Dr. Mehmet Taner Ozdemir is an experienced orthopedic specialist with 7 years in the field. He focuses on oncology, orthopedic trauma, arthroscopic surgery, and bone and soft tissue tumors. He completed his medical and specialist training at GATA Faculty of Medicine in Ankara. He also received advanced training at the Hospital for Special Surgery in New York, USA.
Dr. Ozdemir is a member of the Turkish Orthopedics and Traumatology Association and the European Musculoskeletal Tumor Society. He has written five national and thirteen international publications. He is dedicated to improving orthopedic science. His skills include joint replacements, arthroscopies, and tumor surgeries.
Osteosarcoma treatment in Turkey utilizes a multidisciplinary approach involving limb-sparing surgery, neoadjuvant chemotherapy, and advanced reconstruction. JCI-accredited centers in Istanbul specialize in pediatric and adult bone tumors. They employ 3 Tesla MRI and PET/CT for precise staging and surgical planning.
Bookimed Expert Insight: Patient data shows that choosing a center with a multidisciplinary tumor board is vital. At Anadolu Medical Center, over 150 doctors collaborate on complex cases. This teamwork allows experts like Dr. Bulent Karagoz to synchronize chemotherapy with orthopedic surgery. This coordination often makes limb-sparing procedures possible for patients initially told they needed amputation.
Patient Consensus: Patients emphasize the importance of having the biopsy performed by the same surgical team doing the final operation. They frequently note that seeking second opinions at tertiary centers often reveals reconstruction options that general hospitals might overlook.
Turkey is a premier destination for osteosarcoma treatment due to its concentration of JCI-accredited oncology centers and ESMO-certified specialists. Patients access advanced limb-salvage surgeries and multidisciplinary tumor boards. These facilities provide rapid diagnostics and complex bone resections at significantly lower costs than in Western Europe or the US.
Bookimed Expert Insight: Turkey's popularity stems from high-volume centers like Anadolu Medical Center, which serves 65,000 patients annually. While many assume lower prices mean fewer services, our data shows mid-range packages often include VIP transfers and preoperative tests. Choosing a JCI-accredited facility ensures the same safety standards as top US hospitals for a fraction of the price.
Patient Consensus: Patients note that private Turkish centers offer much faster scheduling for biopsies and surgeries than public systems. Many emphasize the importance of having an English-speaking coordinator to manage follow-up care with doctors back home.
Turkish JCI-accredited hospitals like Anadolu Medical Center and Memorial Sisli are highly recommended for bone cancer. These facilities utilize multidisciplinary tumor boards to manage complex osteosarcoma cases. Specialized centers in Istanbul provide advanced limb-sparing surgeries and high-precision radiotherapy to preserve functional capacity.
Bookimed Expert Insight: High-volume university hospitals like Medipol Mega offer a significant safety advantage for rare bone cancers. Our data shows these institutions maintain 70 departments and 810 beds. This scale ensures dedicated sarcoma specialists are always on-site. Choosing a university-affiliated center often provides access to more specialized pathology teams than smaller private clinics.
Patient Consensus: Patients note it is vital to secure a tumor board review before any surgery. They emphasize choosing Istanbul-based tertiary centers where orthopedic oncology specialists, rather than general surgeons, lead the treatment team.
Osteosarcoma treatment in Turkey typically requires 7 to 10 days for surgery and initial recovery. Complete care including chemotherapy and limb-sparing surgery can span several months. Turkish oncology centers provide JCI-accredited facilities. Patients often undergo staged protocols including preoperative therapy and intensive physical rehabilitation.
Bookimed Expert Insight: Patients often save time by coordinating chemotherapy cycles between their home country and Turkey. Anadolu Medical Center serves over 65,000 patients annually and is affiliated with Johns Hopkins Hospital. Their specialists like Dr. Yesim Yildirim often provide cycle-by-cycle schedules before travel. This allows patients to plan travel around 21-day treatment windows rather than staying abroad for months.
Patient Consensus: Patients emphasize that systemic chemotherapy is the primary time driver rather than the surgery itself. Most note it is helpful to stay nearby for a few weeks after the operation for wound checks and initial physical therapy.
Clinical trials for advanced or recurrent osteosarcoma are available in Turkey. Major centers participate in global Phase 2 and 3 studies. These trials investigate targeted therapies and immunotherapies. Patients often access these through specialized oncology departments at JCI-accredited facilities in Istanbul.
Bookimed Expert Insight: Look for oncologists with specific trial leadership like Dr. Eda Tanrikulu or Dr. Murat Ayhan. Our data shows these doctors have directly managed international clinical studies. This experience is vital for navigating complex trial protocols. Selecting a principal investigator increases your chances of accessing new therapies before they reach standard care. Anadolu Medical Center is a standout as it maintains a dedicated clinical research unit.
Patient Consensus: Patients emphasize the need to confirm eligibility for metastatic cases early. They note that coordinating pathology reviews and imaging schedules is essential for trial screening.
High-quality osteosarcoma care in Turkey is delivered by multidisciplinary tumor boards including orthopedic oncologists, medical oncologists, and specialized radiologists. These teams focus on limb-sparing surgery and personalized chemotherapy protocols. Most centers hold Joint Commission International accreditation to ensure strict safety and treatment standards.
Bookimed Expert Insight: Our data suggests looking for clinics with a high volume of complex oncology cases, like Anadolu Medical Center, which treats 65,000 patients annually. The presence of dedicated multidisciplinary tumor boards is a key quality signal. These boards often include specialists with 20+ years of experience who have completed fellowships at institutions like MD Anderson or Oxford.
Patient Consensus: Patients emphasize the need to confirm that a specialized sarcoma board reviews their case before surgery. They also note that clarity on long-term rehabilitation is vital for successful limb-salvage recovery.